Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study
- PMID: 33584953
- PMCID: PMC7840085
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study
Abstract
BACKGROUND: Alopecia areata and vitiligo vulgaris are common autoimmune diseases whose pathophysiology are not completely elucidated. Genetic susceptibility, immunological background, and stress have significant roles in their pathogenesis. Although macrophage migration inhibitory factor (MIF) is crucial for the maintenance of immune privilege in certain sites, it can upregulate different inflammatory cytokines and contribute to the pathogenesis of different autoimmune diseases. There is controversy about its role in alopecia and no adequate data about its role in vitiligo. OBJECTIVES: We sought to assess the serum level of MIF in alopecia areata and vitiligo and its relationship with different variables of both diseases. METHOD: Serum level of MIF was measured in 20 patients with vitiligo, 22 patients with alopecia areata, and 20 controls by ELISA. RESULTS: MIF was significantly higher in alopecia areata (8.477±4.1761ng/mL) and vitiligo vulgaris (3.930±2.7071ng/mL) compared to controls (0.725±0.5108 ng/mL) (P<0.01). In addition, MIF levels were positively correlated with the severity of alopecia areata and vitiligo. CONCLUSION: The MIF has an active role in the pathogenesis of alopecia areata and vitiligo and could be a target for the treatment of both diseases.
Keywords: MIF; Macrophage migration inhibitory factor; alopecia; immunoregulatory cytokines; vitiligo vulgaris.
Copyright © 2020. Matrix Medical Communications. All rights reserved.
Conflict of interest statement
FUNDING:No funding was provided for this study. DISCLOSURES:The authors have no conflicts of interest related to the content of this article.
Figures




Similar articles
-
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.Braz J Med Biol Res. 2013 May;46(5):460-4. doi: 10.1590/S0100-879X2012007500152. Braz J Med Biol Res. 2013. PMID: 23797494 Free PMC article.
-
Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.J Clin Lab Anal. 2015 Jan;29(1):74-9. doi: 10.1002/jcla.21731. Epub 2014 Mar 28. J Clin Lab Anal. 2015. PMID: 24687398 Free PMC article.
-
Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.Int J Dermatol. 2016 Dec;55(12):1357-1361. doi: 10.1111/ijd.13344. Epub 2016 Jul 15. Int J Dermatol. 2016. PMID: 27420731
-
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.Int J Mol Sci. 2024 Apr 17;25(8):4409. doi: 10.3390/ijms25084409. Int J Mol Sci. 2024. PMID: 38673994 Free PMC article. Review.
-
Understanding autoimmunity of vitiligo and alopecia areata.Curr Opin Pediatr. 2016 Aug;28(4):463-9. doi: 10.1097/MOP.0000000000000375. Curr Opin Pediatr. 2016. PMID: 27191524 Free PMC article. Review.
Cited by
-
Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (Review).Int J Mol Med. 2025 Oct;56(4):149. doi: 10.3892/ijmm.2025.5590. Epub 2025 Jul 19. Int J Mol Med. 2025. PMID: 40682854 Free PMC article. Review.
-
Association Among MIF, IFIH1, and IL6 Gene Polymorphisms and Non-Segmental Vitiligo in a Chinese Han Population.Clin Cosmet Investig Dermatol. 2022 Aug 10;15:1597-1609. doi: 10.2147/CCID.S369418. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35983127 Free PMC article.
-
The Immunogenetics of Alopecia areata.Adv Exp Med Biol. 2022;1367:19-59. doi: 10.1007/978-3-030-92616-8_2. Adv Exp Med Biol. 2022. PMID: 35286691
-
Alopecia Areata: A Review of the Genetic Variants and Immunodeficiency Disorders Associated with Alopecia Areata.Skin Appendage Disord. 2023 Oct;9(5):325-332. doi: 10.1159/000530432. Epub 2023 Jul 4. Skin Appendage Disord. 2023. PMID: 37900769 Free PMC article. Review.
-
Macrophage migration inhibitory factor (rs755622) gene polymorphism in vitiligo.Ir J Med Sci. 2025 Jun;194(3):933-938. doi: 10.1007/s11845-025-03966-9. Epub 2025 May 30. Ir J Med Sci. 2025. PMID: 40445486 Free PMC article.
References
-
- Li S, Zhu G, Yang Y et al. Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. J Allergy Clin Immunol. 2017;1(140):177–89. - PubMed
-
- Ingordo V, Gentile C, Iannazzone SS et al. Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol. 2011;25(1):105–109. - PubMed
-
- Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial?. J Invest Dermatol. 2010;130(11):2535–2537. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous